Genmab
GMAB
17,62 €
Share price
2.51%
Change (1 day)
-34.12%
Change (1 year)
Categories
EPS for Genmab (GMAB)
EPS in 2023 (TTM): 0,98 €
According to Genmab's latest financial reports the company's current EPS (TTM) is 0,88 €. In 2022 the company made an earnings per share (EPS) of 1,02 € an increase over its 2021 EPS that were of 0,63 €.
EPS history for Genmab from 2009 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | 0,98 € | -4.41% |
| 2022 | 1,02 € | 62.07% |
| 2021 | 0,63 € | -35.78% |
| 2020 | 0,98 € | 119.14% |
| 2019 | 0,45 € | 36.35% |
| 2018 | 0,33 € | 29.83% |
| 2017 | 0,25 € | 0.92% |
| 2016 | 0,25 € | 47.69% |
| 2015 | 0,17 € | 109.32% |
| 2014 | 0,08123 € | 134.03% |
| 2013 | 0,03471 € | -121.08% |
| 2012 | -0,16 € | -23.69% |
| 2011 | -0,22 € | 94.77% |
| 2010 | -0,11 € | -70.48% |
| 2009 | -0,38 € |